Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Elanco Animal Health (ELAN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Elanco Animal Health's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
13.46 +0.32    +2.40%
02/05 - Closed. Currency in USD ( Disclaimer )
After Hours
13.57
+0.11
+0.82%
0:02:36 - Real-time Data
  • Volume: 3,895,294
  • Bid/Ask: 12.76 / 16.50
  • Day's Range: 13.17 - 13.53
Type:  Equity
Market:  United States
Elanco Animal Health 13.46 +0.32 +2.40%

ELAN Income Statement & Profits

 
Assess the Elanco Animal Health income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Revenue 1035 1068 1057 1257
Revenue 1035 1068 1057 1257
Other Revenue, Total - - - -
Cost of Revenue, Total 514 487 434 494
Gross Profit 521 581 623 763
Total Operating Expenses 1018 1026 1004 1036
Selling/General/Admin. Expenses, Total 287 313 353 327
Research & Development 79 86 81 81
Depreciation / Amortization -113 33 41 39
Interest Expense (Income) - Net Operating -67 -72 -74 -64
Unusual Expense (Income) - - - -
Other Operating Expenses, Total 318 179 169 159
Operating Income 17 42 53 221
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - - - -
Other, Net 144 1139 132 113
Net Income Before Taxes -127 -1097 -79 108
Provision for Income Taxes 14 -1 18 5
Net Income After Taxes -141 -1096 -97 103
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -141 -1096 -97 103
Total Extraordinary Items - - - -
Net Income -141 -1096 -97 103
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -141 -1096 -97 103
Dilution Adjustment 2.21 -2.21 1.52 -0.488
Diluted Net Income -143.21 -1093.79 -98.52 103.49
Diluted Weighted Average Shares 492.8 492.7 492.6 492.8
Diluted EPS Excluding Extraordinary Items -0.291 -2.22 -0.2 0.21
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.084 -0.049 -0.037 0.188
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ELAN Price Commentary

Write your thoughts about Elanco Animal Health
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Gurkan Ulusoy
Gurkan Ulusoy Nov 06, 2020 15:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Unless they prove the success of Bayer integration and report aggregated growth and profitability, investors will continue to approach with questions in mid term.
Gurkan Ulusoy
Gurkan Ulusoy Nov 06, 2020 15:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Unless they prove the success of Bayer integration and report aggregated growth and profitability, investors will continue to approach with questions in mid term.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email